RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. F2G

F2G

F2G develops novel therapeutics for rare, life-threatening fungal infections.

Latest funding

$100M Series B+ ·

Led by AMR Action Fund · Source: fundraisingfox.com

Funding history ↓
Website: f2g.com.
LinkedIn: linkedin.com.
Sectors: Biotechnology, Genetics, Health Care, Medical, Pharmaceutical.
Stage: Series B+.
Based in: Manchester, United Kingdom.
Last round: Sep 12, 2024 · 795 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredNov 22, 1999 (27 years old)
About F2G

The company creates new antifungal drugs, including olorofim, which is part of a new class of antifungal drugs called orotomides. F2G aims to provide more treatment options for patients fighting these infections.

Funding rounds

DateRoundAmountLeadSource
Series B+$100MAAMR Action Fundfundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like F2G

Other companies backed by AMR Action Fund

AMR Action Fund portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/f2g (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy